Thrombotic microangiopathy: Efficacy of eculizumab in paediatric aHUS

Nature Reviews Nephrology 12, 198 (2016). doi:10.1038/nrneph.2016.24 Author: Andrea Aguilar Eculizumab is currently the only approved treatment for atypical haemolytic uraemic syndrome (aHUS), but data in paediatric patients are limited. Recent findings from a prospective phase II study in 22 children with aHUS suggest that eculizumab is safe and efficacious in this setting. After 26

http://feeds.nature.com/~r/nrneph/rss/current/~3/KjCFmc4u-ks/nrneph.2016.24

Source: Nature Reviews Nephrology - February 22, 2016 Category: Urology & Nephrology Authors: Andrea Aguilar Tags: Research Highlight Source Type: research

More News: Children | Hemolytic Uremic Syndrome (HUS) | Pediatrics | Study | Urology & Nephrology